Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus stellate ganglion block for postoperative sleep disorders
ChiCTR2600117939Phase 4Not yet recruiting
- Sponsor
- North China University of Science and Technology Affiliated Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in sleep disorder, postoperative pain and Postoperative hyperalgesia (4 arms), sponsored by North China University of Science and Technology Affiliated Hospital. Primary endpoints: State Entropy (SE), Response Entropy (RE) and 1 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorderpostoperative painPostoperative hyperalgesia
Beyond the preview
Go deeper on ChiCTR2600117939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117939.